Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: The role of pigmentary genes

British Journal of Dermatology

Volumn 151, Issue 2, 2004, Pages 269-282

  Taibjee, S M ^a   Bennett, D C ^b   Moss, C ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Chromosomal abnormalities; Hypomelanosis of Ito; Karyotype; Linear and whorled naevoid hypermelanosis; Pigmentary genes; Pigmentary mosaicism

Indexed keywords

AUTOSOME MOSAICISM; CELL MIGRATION; CHROMOSOME MOSAICISM; GENE EXPRESSION; GENE LOCUS; GENE TRANSLOCATION; GENOME IMPRINTING; HUMAN; HYPERPIGMENTATION; INCONTINENTIA PIGMENTI; KARYOTYPE; MELANOGENESIS; NONHUMAN; PHENOTYPE; PIGMENTED NEVUS; PRIORITY JOURNAL; REVIEW; TRANSPOSON; X CHROMOSOME ABERRATION;

CHROMOSOMES, HUMAN, X; DATABASES, FACTUAL; DNA TRANSPOSABLE ELEMENTS; FEMALE; GENOMIC IMPRINTING; HUMANS; HYPOPIGMENTATION; KARYOTYPING; MALE; MOSAICISM; PHENOTYPE; PIGMENTATION; TRANSLOCATION, GENETIC;

EID: 4544268599     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06057.x     Document Type: Review

References (160)

1. Smahi A, Courtois G, Vabres P et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 2000; 405: 466-72.
2. Thomas IT, Frias JL, Cantu ES et al. Association of pigmentary anomalies with chromosomal and genetic mosaicism and chimerism. Am J Hum Genet 1989; 45: 193-205.
3. Loomis CA. Linear hypopigmentation and hyperpigmentation including mosaicism. Semin Cutan Med Surg 1997; 16: 44-53.
4. Happle R. Mosaicism in human skin. Arch Dermatol 1993; 129: 1460-70.
5. Moss C, Larkins S, Stacey M et al. Epidermal mosaicism and Blaschko's lines. J Med Genet 1993; 30: 752-5.
6. Findlay GH, Moores PP. Pigment anomalies of the skin in the human chimaera: their relation to systematized naevi. Br J Dermatol 1980; 103: 489-98.
7. Donnai D, Read AP, McKeown C, Andrews A. Hypomelanosis of Ito: a manifestation of mosaicism or chimerism. J Med Genet 1988; 25: 809-18.
8. Lyon MF. Sex chromatin and gene action in the mammalian X chromosome. Am J Hum Genet 1962; 14: 135-48.
9. Ballabio A, Willard HF. Mammalian X-chromosome inactivation and the XIST gene. Curr Opin Genet Dev 1992; 2: 439-47.
10. Fritz B, Kuster W, Orstavik KH et al. Pigmentary mosaicism in hypomelanosis of Ito: further evidence for functional disomy of Xp. Hum Genet 1998; 103: 441-9.
11. Hatchwell E, Robinson D, Crolla JA, Cockwell AE. X inactivation analysis in a female with hypomelanosis of Ito associated with a balanced X:17 translocation: evidence for functional disomy of Xp. J Med Genet 1996; 33: 216-20.
12. Happle R. Transposable elements and the lines of Blaschko: a new perspective. Dermatology 2002; 204: 4-7.
13. De Sepulveda P, Guenet J-L, Panthier J-J. Phenotypic reversions at the W/Kit locus mediated by mitotic recombination in mice. Mol Cell Biol 1995; 15: 5898-905.
14. Edery P, Attie T, Amiel J et al. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet 1996; 12: 442-4.
15. Pastural E, Barrat FJ, Dufourcq-Lagelouse R et al. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet 1997; 16: 289-92.
16. Cecchi C, Biasotto M, Tosi M, Avner P. The mottled mouse as a model for human Menkes disease: identification of mutations in the Atp7a gene. Hum Mol Genet 1997; 6: 425-33.
17. Dell'Angelica EC, Shotelersuk V, Aguilar RC et al. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta3A subunit of the AP-3 adaptor. Mol Cell 1999; 3: 1-20.
18. Sánchez-Martín M, Pérez-Losada J, Rodríguez-García A et al. Deletion of the SLUG (SNAI2) gene results in human piebaldism. Am J Med Genet 2003; 122: 125-32.
19. Bennett DC, Lamoreux ML. The color loci of mice - a genetic century. Pigment Cell Res 2003; 16: 1-12.
20. Spritz RA, Chiang PW, Oiso N, Alkhateeb A. Human and mouse disorders of pigmentation. Curr Opin Genet Dev 2003; 13: 284-9.
21. Fukai K, Ishii M, Wakamatsu K et al. Selective decrease of eumelanin in hypopigmented epidermis of hypomelanosis of Ito. Pediatr Dermatol 1994; 11: 261-3.
22. Pellegrino JE, Schnur RE, Kline R et al. Mosaic loss of 15q11q13 in a patient with hypomelanosis of Ito: is there a role for the P gene? Hum Genet 1995; 96: 485-9.
23. Spritz RA. Molecular basis of human piebaldism. J Invest Dermatol 1994; 103: S137-40.
24. del Marmol V, Beermann F. Tyrosinase and related proteins in mammalian pigmentation. FEBS Lett 1996; 381: 165-8.
25. Nordlund JJ, Boissy RE, Hearing VJ et al. The Pigmentary System: Physiology and Pathophysiology, 1st edn. Oxford: Oxford University Press, 1998.
26. Spritz RA. Multi-organellar disorders of pigmentation. Trends Genet 1999; 15: 337-40.
27. Bennett DC. Colour genes, oncogenes and melanocyte differentiation. J Cell Sci 1991; 98: 135-9.
28. Oetting WS, Bennett DC. Mouse Coat Color Genes. International Federation of Pigment Cell Societies. 2003 (http://www.cbc.umn.edu/ifpcs/micemut.htm).
29. Online Mendelian Inheritance in Man. OMIM™. Baltimore. MD: Johns Hopkins University (http://www.ncbi.nlm.nih.gov/omim/).
30. Santiago A, Erickson CA. Ephrin-B ligands play a dual role in the control of neural crest cell migration. Development 2002; 129: 3621-32.
31. Takayama H, LaRocelle WJ, Anver M et al. Scatter factor/HGF as a regulator of skeletal muscle and neural crest development. Proc Natl Acad Sci USA 1996; 93: 5866-71.
32. Rieger E, Kofler R, Borkenstein M et al. Melanotic macules following Blaschko's lines in McCune-Albright syndrome. Br J Dermatol 1994; 130: 215-20.
33. Woods CG, Bankier A, Curry J et al. Asymmetry and skin pigmentary anomalies in chromosomal mosaicism. J Med Genet 1994; 31: 694-701.
34. Fujimoto A, Ming SL, Korula SR, Wilson MG. Trisomy 14 mosaicism with t(14:15)(q11;p11) in offspring of a balanced translocation carrier mother. Am J Med Genet 1985; 22: 333-42.
35. Neri G, Ricci R, Pelino A et al. A boy with ring chromosome 15 derived from a t(15q:15q) Robertsonian translocation in the mother: cytogenetic and biochemical findings. Am J Med Genet 1983; 14: 307-14.
36. Turleau C, Taillard F, Doussau de Bazignan M et al. Hypomelanosis of Ito and mosaicism for a microdeletion of 15q1. Hum Genet 1986; 74: 185-7.
37. Millonig JH, Millen KJ, Hatten ME. The mouse Dreher gene Lmx1a controls formation of the roof plate in the vertebrate CNS. Nature 2000; 403: 764-9.
38. Dreyer SD, Zhou G, Baldini A et al. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet 1998; 19: 47-50.
39. Di Palma F, Belyantseva IA, Kim HJ et al. Mutations in Mcoln3 associated with deafness and pigmentation defects in varitint-waddler (Va) mice. Proc Natl Acad Sci USA 2002; 99: 14994-9.
40. Easty DJ, Hill SP, Hsu MY et al. Up-regulation of ephrin-A1 during melanoma progression. Int J Cancer 1999; 84: 494-501.
41. Nagle DL, Karim MA, Woolf EA et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 1996; 14: 307-11.
42. Saitoh T, Hirai M, Katoh M. Molecular cloning and characterization of WNT3A and WNT14 clustered in human chromosome 1q42 region. Biochem Biophys Res Commun 2001; 284: 1168-75.
43. Krude H, Biebermann H, Luck W et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998; 19: 155-7.
44. Peschon JJ, Slack JL, Reddy P et al. An essential role for ecto-domain shedding in mammalian development. Science 1998; 282: 1281-4.
45. Tassabehji M, Newton VE, Leverton K et al. PAX3 gene structure and mutations: close analogies between Waardenburg syndrome and the Splotch mouse. Hum Mol Genet 1994; 3: 1069-74.
46. Matesic LE, Yip R, Reuss AE et al. Mutations in Mlph. encoding a member of the Rab effector family, cause the melanosome transport defects observed in leaden mice. Proc Natl Acad Sci USA 2001; 98: 10238-43.
47. Moore KJ. Insight into the microphthalmia gene. Trends Genet 1995; 11: 442-8.
48. Anikster Y, Huizing M, White J et al. Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico. Nat Genet 2001; 28: 376-80.
49. Ciciotte SL, Gwynn B, Moriyama K et al. Cappuccino, a mouse model of Hermansky-Pudlak syndrome, encodes a novel protein that is part of the pallid-muted complex (BLOC-1). Blood 2003; 101: 4402-7.
50. Giebel LB, Spritz RA. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci USA 1991; 88: 8696-9.
51. Harada M, Li YF, El-Gamil M et al. Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A*0201-restricted T cells. Cancer Res 2001; 61: 1089-94.
52. Höning S, Sandoval IV, von Figura K. A di-leucine-based motif in the cytoplasmic tail of LIMP-II and tyrosinase mediates selective binding of AP-3. EMBO J 1998; 17: 1304-14.
53. Fleming MD, Campagna DR, Haslett JN et al. A mutation in a mitochondrial transmembrane protein is responsible for the pleiotropic haematological and skeletal phenotype of flexed-tail (f/f) mice. Genes Dev 2001; 15: 652-7.
54. Zhang Q, Li W, Novak EK et al. The gene for the muted (mu) mouse, a model for Hermansky-Pudlak syndrome, defines a novel protein which regulates vesicle trafficking. Hum Mol Genet 2002; 11: 697-706.
55. Chalhoub N, Benachenhou N, Rajapurohitam V et al. Grey-lethal mutation induces severe malignant autosomal osteopetrosis in mouse and human. Nat Med 2003; 9: 399-406.
56. Fitch KR, McGowan KA, van Raamsdonk CD et al. Genetics of dark skin in mice. Genes Dev 2003; 17: 214-28.
57. Anderson MG, Smith RS, Hawes NL et al. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet 2002; 30: 81-5.
58. Savagner P, Yamada KM, Thiery JP. The zinc-finger protein Slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 1997; 137: 1403-19.
59. Murty V, Bouchard B, Matthew S et al. Assignment of the human TYRP (brown) locus to chromosome region 9p23 by nonradioactive in situ hybridization. Genomics 1992; 13: 227-9.
60. Halaban R, Moellmann G. Murine and human b locus pigmentation genes encode a glycoprotein with catalase activity. Proc Natl Acad Sci USA 1990; 87: 4809-13.
61. Oh J, Bailin T, Fukai K et al. Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet 1996; 14: 300-6.
62. Zhang Q, Zhao B, Li W et al. Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6. Nat Genet 2003; 33: 145-54.
63. Liu X, Ondek B, Williams DS. Mutant myosin VIIa causes defective melanosome distribution in the RPE of shaker-1 mice (letter). Nat Genet 1998; 19: 117-18.
64. Hearing V, Tsukamoto K. Enzymatic control of pigmentation in mammals. FASEB J 1991; 5: 2902-9.
65. Loftus SK, Larson DM, Baxter LL et al. Mutation of melanosome protein RAB38 in chocolate mice. Proc Natl Acad Sci USA 2002; 99: 4471-6.
66. Rao C, Foernzler D, Loftus SK et al. A defect in a novel ADAMTS family member is the cause of the belted white-spotting mutation. Development 2003; 130: 4665-72.
67. McMahon AP. The Wnt family of developmental regulators. Trends Genet 1992; 8: 236-42.
68. Martínez-Esparza M, Jiménez-Cervantes C, Solano F et al. The murine silver locus: coding and expression of a single transcript truncated by the silver mutation. Mamm Genome 1999; 10: 1168-71.
69. Jackson IJ. Molecular and developmental genetics of mouse coat color. Annu Rev Genet 1994; 28: 189-217.
70. Suzuki T, Oiso N, Gautam R et al. The mouse organellar biogenesis mutant buff results from a mutation in Vps33a, a homologue of yeast vps33 and Drosophila carnation. Proc Natl Acad Sci USA 2003; 100: 1146-50.
71. Kuo Y-M, Gitschier J, Packman S. Developmental expression of the mouse mottled and toxic milk genes suggests distinct functions for the Menkes and Wilson disease copper transporters. Hum Mol Genet 1997; 6: 1043-9.
72. Puffenberger EG, Hosoda K, Washington SS et al. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 1994; 79: 1257-66.
73. Sturm RA, Box NF, Ramsay M. Human pigmentation genetics: the difference is only skin deep. Bioessays 1998; 20: 712-21.
74. Jackson IJ, Chambers D, Tsukamoto K et al. A second tyrosinase-related protein. TRP-2, maps to and is mutated at the mouse slaty locus. EMBO J 1992; 11: 527-35.
75. Bouchard B, del Marmol V, Jackson IJ et al. Molecular characterization of a human tyrosinase-related-protein-2 cDNA. Patterns of expression in melanocytic cells. Eur J Biochem 1994; 219: 127-34.
76. van Bokhoven H, Rawson RB, Merkx GFM et al. cDNA cloning and chromosomal localization of the genes encoding the alpha-and beta-subunits of human Rab geranylgeranyl transferase: the 3-prime end of the alpha-subunit gene overlaps with the transglutaminase 1 gene promoter. Genomics 1996; 38: 133-40.
77. Ramsay M, Colman MA, Stevens G et al. The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12. Am J Hum Genet 1992; 51: 879-84.
78. Rinchik EM, Bultman SJ, Horsthemke B et al. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature 1993; 361: 72-6.
79. White RA, Peters LL, Adkison LR et al. The murine pallid mutation is a platelet storage pool disease associated with the protein 4.2 (pallidin) gene. Nat Genet 1992; 2: 80-3.
80. Hume AN, Collinson LM, Hopkins CR et al. The leaden gene product is required with Rab27a to recruit myosin Va to melanosomes in melanocytes. Traffic 2002; 3: 193-202.
81. German J, Roe AM, Leppert MF, Ellis NA. Bloom syndrome: an analysis of consanguineous families assigns the locus mutated to chromosome band 15q26.1. Proc Natl Acad Sci USA 1994; 91: 6669-73.
82. Phan LK, Lin F, LeDuc CA et al. The mouse mahoganoid coat color mutation disrupts a novel C3HC4 RING domain protein. J Clin Invest 2002; 110: 1449-59.
83. Valverde P, Healy E, Jackson I et al. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 1995; 11: 328-30.
84. Kirschner LS, Sandrini F, Monbo J et al. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum Mol Genet 2000; 9: 3037-46.
85. Nakayama K, Nakayama K, Negishi I et al. Targeted disruption of Bcl-2-alpha-beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 1994; 91: 3700-4.
86. Puttagunta R, Gordon LA, Meyer GE et al. Comparative maps of human 19p13.3 and mouse chromosome 10 allow identification of sequences at evolutionary breakpoints. Genome Res 2000; 10: 1369-80.
87. Jenne DE, Reimann H, Nezu J et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998; 18: 38-43.
88. Taylor EM, Broughton BC, Botta E et al. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc Natl Acad Sci USA 1997; 94: 8658-63.
89. Gunn TM, Miller KA, He L et al. The mouse mahogany locus encodes a transmembrane form of human attractin. Nature 1999; 398: 152-6.
90. Wilson BD, Wilson BD, Ollmann MM et al. Structure and function of ASP, the human homolog of the mouse agouti gene. Hum Mol Genet 1995; 4: 223-30.
91. Baynash AG, Hosoda K, Giaid A et al. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 1994; 79: 1277-85
92. Pennisi D, Gardner J, Chambers D, Hosking B. Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice. Nat Genet 2000; 24: 434-7.
93. Lieberman MW, Wiseman AL, Shi ZZ et al. Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci USA 1996; 93: 7923-6.
94. Suzuki T, Li W, Zhang O et al. Hermansky-Pudlak syndrome is caused by mutations in HPS4, the human homologue of the mouse light-ear gene. Nat Genet 2002; 30: 321-4.
95. Southard-Smith EM, Kos L, Pavan WJ. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet 1998; 18: 60-4.
96. Bassi MT, Schiaffino MV, Renieri A et al. Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome. Nat Genet 1995; 10: 13-19.
97. Nolan PM, Peters J, Strivens M et al. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet 2000; 25: 440-3.
98. Shiloh Y, Litvak G, Ziv Y et al. Genetic mapping of X-linked albinism-deafness syndrome (ADFN) to Xq26.3-q27.I. Am J Hum Genet 1990; 47: 20-7.
99. Heiss NS, Knight SW, Vulliamy TJ et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998; 19: 32-8.
100. Ruiz-Maldonado R, Toussaint S, Tamayo L et al. Hypomelanosis of Ito: diagnostic criteria and report of 41 cases. Pediatr Dermatol 1992; 9: 1-10.
101. Miller CA, Parker WD Jr. Hypomelanosis of Ito: association with a chromosomal abnormality. Neurology 1985; 35: 607-10.
102. Stanley WS, Powell CM, Devine GC et al. Mosaic 5p tetrasomy. Am J Med Genet 1993; 45: 774-6.
103. Bitoun P, Philippe C, Cherif M et al. Incontinentia pigmenti (type 1) and X:5 translocation. Ann Genet 1992; 35: 51-4.
104. Jenkins D, Martin K, Young ID. Hypomelanosis of Ito associated with mosaicism for trisomy 7 and apparent 'pseudomosaicism' at amniocentesis. J Med Genet 1993; 30: 783-4.
105. Verghese S, Newlin A, Miller M, Burton BK. Mosaic trisomy 7 in a patient with pigmentary abnormalities. Am J Med Genet 1999; 87: 371-4.
106. DeLozier-Blanchet CD, Guenin R. Cytogenetics of ring chromosome 7. Clin Genet 1984; 25: 84-7.
107. Akefeldt A, Gillberg C. Hypomelanosis of Ito in three cases with autism and autistic-like conditions. Dev Med Child Neurol 1991; 33: 737-43.
108. Eussen BHJ, Bartalina G, Bakker L et al. An unbalanced submicroscopic translocation t(8:16)(q24.3:p13.3)pat associated with tuberous sclerosis complex, adult polycystic kidney disease, and hypomelanosis of Ito. J Med Genet 2000; 37: 287-91.
109. Dereser-Dennl M, Brude E, Konig R. [Hypomelanosis of Ito in translocation trisomy 9/mosaicism (46.XX/46.XX.t (9:9) (p24:p24)). Spontaneous remission in childhood]. [German] Hautarzt 2000; 51: 688-92.
110. Hodgson SV, Neville B, Jones RWA et al. Two cases of X/autosome translocation in females with incontinentia pigmenti. Hum Genet 1985; 71: 231-4.
111. Gilgenkrantz S, Tridon P, Pinel-Briquel N et al. Translocation (X:9)(p11:q34) in a girl with incontinentia pigmenti: implications for the regional assignment of the IP locus to Xp11? Ann Genet 1985; 28: 90-2.
112. Toriello HV, Glover TW, Takahar K et al. A translocation interrupts the COL5A1 gene in patient with Ehlers-Danlos syndrome and hypomelanosis of Ito. Nat Genet 1996; 13: 361-5.
113. Donnai D, McKeown C, Andrews T, Read AP. Diploid/triploid mixoploidy and hypomelanosis of Ito. Lancet 1986; i: 1443-4.
114. Koiffmann CP, de Souza DH, Diament A et al. Hypomelanosis of Ito: further evidence of localisation at Xp11. Am J Med Genet 1993; 46: 529-33.
115. Boon C, Martello T, Jackson-Cook C, Pandya A. Partial trisomy 10 mosaicism with cutaneous manifestations: a report of a case and review of the literature. Clin Genet 1996; 50: 417-21.
116. Canizzaro LA, Hecht F. Gene for incontinentia pigmenti maps to band Xp11 with an (X:10)(p11:q22) translocation. Clin Genet 1987; 32: 66-9.
117. English CJ, Goodship JA, Jackson A. Trisomy 12 mosaicism in a 7 year old girl with dysmorphic features and normal mental development. J Med Genet 1994; 31: 253-4.
118. Hersh JH, Graham JG, Destrempes MM, Greenstein RM. Teschler-Nicola/ Killian syndrome: a case report. J Clin Dysmorph 1983; 1: 20-2.
119. Sybert VP. Hypomelanosis of Ito: a description, not a diagnosis. J Invest Dermatol 1994; 103: S141-3.
120. Carey JC, Morgan C, Palumbos JC et al. The Pallister mosaic. Killian and 12p marker syndromes: evolution of a single entity. Proc Green Gen Cent 1986; 5: 131.
121. Hall BD. Long-term phenotypic follow-up of three males with tetrasomy 12p (Pallister mosaic syndrome). Proc Green Gen Cent 1985; 5: 132.
122. Schmidt H, Uhrig S, Lederer G et al. Mosaicism for a dup(12)(q22q13) in a patient with hypomelanosis of Ito and asymmetry. J Med Genet 2000; 37: 804-6.
123. Thomas IT, Frias JL. Hypomelanosis of Ito and chromosomal mosaicism in fibroblasts. Lancet 1986; ii: 343.
124. Happle R. Phylloid hypomelanosis is closely related to mosaic trisomy 13. Eur J Dermatol 2000; 10: 511-12.
125. Wilson WG, Shires MA, Willson KA et al. Trisomy 18/trisomy 13 mosaicism in an adult with profound mental retardation and multiple malformations. Am J Med Genet 1983; 16: 131-6.
126. Abe T, Misawa S, Nishioka K et al. Formation of a ring chromosome 14 subsequent to the de novo 13/14 reciprocal translocation: a new cytogenetic evidence obtained by the nucleolus-organizer staining. Ann Genet 1978; 21: 109-12.
127. Correa-Cerro LS, Rivera H, Vasquez AI. Functional Xp disomy and de novo t(X:13)(q10:q10) in a girl with hypomelanosis of Ito. J Med Genet 1997; 34: 161-3.
128. Rivera H, Correa-Cerro LS, Robinson DO, Crolla JA. Functional Xp disomy and hypomelanosis of Ito. Arch Med Res 2000; 31: 88-92.
129. Kajii T, Tsukahara M, Fukushima Y et al. Translocation (X:13)(p11.21:q12.3) in a girl with incontinentia pigmenti and bilateral retinoblastoma. Ann Genet 1985; 28: 219-23.
130. Johnson VP, Acheto T, Likness C. Trisomy 14 mosaicism, case report and review. Am J Med Genet 1979; 3: 331-9.
131. Kuwahara RT, Henson T, Tunca Y, Wilroy SW. Hyperpigmentation along the lines of Blaschko associated with chromosome 14 mosaicism. Pediatr Dermatol 2001; 18: 360-1.
132. Schmidt R, Eviatar L, Nitowsky HM et al. Ring chromosome 14: a distinct clinical entity. J Med Genet 1981; 18: 304-20.
133. Tunca Y, Wilroy RS, Kadandale JS et al. Hypomelanosis of Ito and a 'mirror image' whole chromosome duplication resulting in trisomy 14 mosaicism. Ann Genet 2000; 43: 39-43.
134. Ishikawa T, Kanayama M, Sugiyama K et al. Hypomelanosis of Ito associated with benign tumours and chromosomal abnormalities: a neurocutaneous syndrome. Brain Dev 1985; 7: 45-9.
135. Penchaszadeh VB, Babu A, Schwartz M et al. Hypomelanosis of Ito in a girl with a de novo translocation (X:14)(q11:q13). Am J Hum Genet 1989: 45 (Suppl.): A219.
136. Bernstein R, Dawson B, Kohl R, Jenkins T. X:15 translocation in a retarded girl: X inactivation pattern and attempt to localise the hexosaminidase A and other loci. J Med Genet 1979; 16: 254-62.
137. Crolla JA, Gilgenkrantz S, de Grouchy J et al. Incontinentia pigmenti and X-autosomal translocations: non-isotopic in situ hybridisation with an X-centromere-specific probe reveals a possible centromeric breakpoint in one of five published cases. Hum Genet 1989; 81: 269-72.
138. Steichen-Gersdorf E, Trawoger R, Duba HC et al. Hypomelanosis of Ito in a girl with plexus papilloma and translocation (X:17). Hum Genet 1993; 90: 611-13.
139. Zajac V, Kirchhoff T, Levy ER et al. Characterisation of X:17(q12:p13) translocation breakpoints in a female patient with hypomelanosis of Ito and choroid plexus papilloma. Eur J Hum Genet 1997; 5: 61-8.
140. Chemke J, Rappaport S, Etrog R. Aberrant melanoblast migration associated with trisomy 18 mosaicism. J Med Genet 1983; 20: 135-7.
141. Chitayat D, Friedman JM, Johnston MM. Hypomelanosis of Ito - a non-specific marker of somatic mosaicism: report of case with trisomy 18 mosaicism. Am J Med Genet 1990; 35: 422-4.
142. Murano I, Ohashi H, Tsukahara H et al. Pigmentary dysplasias in long survivors with mosaic trisomy 18: report of two cases. Clin Genet 1991; 39: 68-74.
143. Uehara S, Obara Y, Obara T. Trisomy 18 mosaicism associated with secondary amenorrhoea: ratios of mosaicism in different samples and complications. Clin Genet 1996; 49: 91-4.
144. Atnip RL, Summitt RL. Tetraploidy and 18-trisomy in a six year old triple mosaic boy. Cytogenetics 1971; 10: 305-17.
145. Bocian E, Mazurzak T, Bulawa E et al. Triple structural mosaicism of chromosome 18 in a child with MR/MCA syndrome and abnormal skin pigmentation. J Med Genet 1993; 30: 614-15.
146. Lungarotti MS, Martello C, Calabro A et al. Hypomelanosis of Ito associated with translocation involving Xp11. Am J Med Genet 1991; 40: 447-8.
147. Lacour JP, Pedeutour F, Aberdam E et al. Cytogenetic and functional studies of melanocytes in pigmentary mosaicism of the Ito type: preliminary results. Br J Dermatol 2003; 149 (Suppl. 64): 76 (Abstr.).
148. Baty BJ, Olson SB, Magenis RE, Carey JC. Trisomy 20 mosaicism in two unrelated girls with skin hypopigmentation and normal intellectual development. Am J Med Genet 2001; 99: 210-16.
149. Crowe CA, Schwartz S, Black CJ, Jaswaney V. Mosaic trisomy 22: a case presentation and literature review of trisomy 22 phenotypes. Am J Med Genet 1997; 71: 406-13.
150. Wertelecki W, Breg WR, Graham JM et al. Trisomy 22 mosaicism syndrome and Ullrich-Turner stigmata. Am J Med Genet 1986; 23: 739-49.
151. Ritter CL, Steele MW, Wenger SL, Cohen BA. Chromosome mosaicism in hypomelanosis of Ito. Am J Med Genet 1990; 35: 14-17.
152. De Grouchy J, Turleau C, Doussau de Bazignan M et al. Incontinentia pigmenti and r(X): tentative mapping of the IP locus to the X juxtacentromeric region. Ann Genet 1985; 28: 86-9.
153. Dennis NR, Collins AL, Crolla JA. Three patients with ring (X) chromosomes and a severe phenotype. J Med Genet 1993; 30: 482-6.
154. Rott H-D, Ulmer R, Haneke E. Hypomelanosis of Ito and chromosomal mosaicism in fibroblasts. Lancet 1986; ii: 343.
155. Sefiani A, Heuertz S, Turleau C et al. Incontinentia pigmenti: Xp breakpoint is not the same in a case of r(X) and in X/autosome translocations. Ann Genet 1989; 32: 149-51.
156. Flannery DB, Byrd JR, Freeman WE, Perlman SA. Hypomelanosis of Ito: a cutaneous marker of chromosomal mosaicism. Am J Hum Genet 1985; 37: A93.
157. Kubota Y, Shimura Y, Shimada S. Linear and whorled nevoid hypermelanosis in a child with chromosomal mosaicism. Int J Dermatol 1992; 31: 345-7.
158. Fulton AB, Howard RO, Albert DM et al. Ocular findings in triploidy. Am J Ophthalmol 1977; 84: 859-67.
159. Wulfsberg EA, Wassel W, Polo CA. Monozygotic twin girls with diploid/triploid chromosome mosaicism and cutaneous pigmentary dysplasia. Clin Genet 1991; 39: 370-5.
160. Vormittag W, Ensinger C, Raff M. Cytogenetic and dermatoglyphic findings in a familial case of hypomelanosis of Ito. Clin Genet 1992; 41: 309-14.